In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Choosing the best treatment approach to dyslipidemia: monotherapy vs combination therapy
Session

Event : ESC Congress 2020

Topic : Drug therapy

  • Session type : Industry Q&A session
  • Date : 31 August 2020
  • Time : 18:30 - 19:30
  • Sponsored by SERVIER

This content is currently on FREE ACCESS

 

7 presentations in this session

ESC Guidelines 2019: what has changed?

Event : ESC Congress 2020

  • Session : Choosing the best treatment approach to dyslipidemia: monotherapy vs combination therapy
  • Speaker : A Zambon (Padua,IT)
  • Sponsored by SERVIER

What is the key evidence supporting LDL-C control at lower targets, with earlier intervention for better outcomes in the long-term?

Event : ESC Congress 2020

  • Session : Choosing the best treatment approach to dyslipidemia: monotherapy vs combination therapy
  • Speaker : L Perez De Isla (Madrid,ES)
  • Sponsored by SERVIER

Broader usage of combinations in daily clinical practice: what benefits for patients?

Event : ESC Congress 2020

  • Session : Choosing the best treatment approach to dyslipidemia: monotherapy vs combination therapy
  • Speaker : A Zambon (Padua,IT)
  • Sponsored by SERVIER

How have the French and Spanish (local) Cardiology Societies interpreted the ESC Guidelines? Insights and recommendations.

Event : ESC Congress 2020

  • Session : Choosing the best treatment approach to dyslipidemia: monotherapy vs combination therapy
  • Speaker : L Perez De Isla (Madrid,ES)
  • Sponsored by SERVIER

Statin/ezetimibe combinations: data and evidence, for which patients.

Event : ESC Congress 2020

  • Session : Choosing the best treatment approach to dyslipidemia: monotherapy vs combination therapy
  • Speaker : A Zambon (Padua,IT)
  • Sponsored by SERVIER

Feedback on patients treated with high intensity statin/ezetimibe combinations. Do we need to go further?

Event : ESC Congress 2020

  • Session : Choosing the best treatment approach to dyslipidemia: monotherapy vs combination therapy
  • Speaker : A Zambon (Padua,IT)
  • Sponsored by SERVIER

Feedback on patients treated with high intensity statin/ezetimibe combinations. Do we need to go further?

Event : ESC Congress 2020

  • Session : Choosing the best treatment approach to dyslipidemia: monotherapy vs combination therapy
  • Speaker : L Perez De Isla (Madrid,ES)
  • Sponsored by SERVIER

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are